Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2000
10/03/2000CA2000342C Novel peptidase inhibitors
10/03/2000CA2000336C Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
09/2000
09/28/2000WO2000057190A2 Prediction of diabetes impaired wound healing
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056711A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056709A1 Indolinone compounds as kinase inhibitors
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056356A2 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
09/28/2000WO2000056341A1 Chemical compounds and their uses
09/28/2000WO2000056337A1 Agents for relieving side effects
09/28/2000WO2000056317A1 Weight loss after pregnancy
09/28/2000WO2000056313A1 Method of controlling weight gain associated with therapeutic drugs
09/28/2000WO2000056167A1 A method of preventing parturient hypocalcemia in animals and compositions used therein
09/28/2000WO2000040693A3 Expression of secreted human alpha-fetoprotein in transgenic animals
09/28/2000WO2000028332A9 Methods and compositions to lower plasma cholesterol levels
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000CA2855415A1 Phenylalanine derivatives
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2512479A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2512291A1 Pro4356 polypeptides and nucleic acids encoding the same
09/28/2000CA2510982A1 Lectin-like protein, pro1890, encoding nucleic acids, pro1890 antibodies and uses thereof
09/28/2000CA2510931A1 Pro4334 polypeptides and nucleic acids
09/28/2000CA2510806A1 Screted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2368733A1 Phenylalanine derivatives
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2368041A1 Indolinone compounds as kinase inhibitors
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367268A1 Weight loss after pregnancy
09/28/2000CA2367132A1 Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
09/28/2000CA2367021A1 Method of controlling weight gain associated with therapeutic drugs
09/28/2000CA2366877A1 Chemical compounds and their uses
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2366080A1 Prediction of diabetes impaired wound healing by urinary nitrate assay
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2362700A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis
09/27/2000EP1038527A1 Process for producing granulates containing riboflavine
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037922A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
09/27/2000EP1037915A1 Matrix-remodeling genes
09/27/2000EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT
09/27/2000EP1037666A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037644A1 Compositions and methods for weight reduction
09/27/2000EP1037636A1 Inhibition of membrane-associated viral replication
09/27/2000EP1037624A1 Methods and compositions for treating diabetes
09/27/2000EP1037623A1 Antihyperlipidemic statin-lp(a) inhibitor combinations
09/27/2000EP1037612A1 Pharmaceutical compositions containing micronized bicyclic drugs
09/27/2000CN1268186A i (in vivo) use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/27/2000CN1268123A Benzimidazole derivatives
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268053A Combination therapy comprising atorvastatin and an antihypertensive agent
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/26/2000US6124460 Isoquinuclidine derivatives, method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds
09/26/2000US6124456 Adenosine antagonists
09/26/2000US6124360 Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid
09/26/2000US6124347 Have inhibitory action against the formation of advanced glycation end-products and are useful as pharmaceuticals for the prevention and treatment of various adult diseases, especially diabetic complications
09/26/2000US6124320 Treating with non-sedating antihistamines without causing cardiac arrhythmias
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124281 Azolobenzazepine derivatives as neurologically active agents
09/26/2000CA2270306C Pharmaceutical compositions comprising co-micronized fenofibrate
09/21/2000WO2000055634A1 Grb14 and the insulin receptor and screening of novel medicines
09/21/2000WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055196A1 Protamine fragment compositions and methods of use
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
1 ... 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 ... 1298